)
)
Leap Therapeutics Investor Relations Material
Latest events
Study Update
Leap Therapeutics
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Leap Therapeutics Inc
Access all reports
Leap Therapeutics Inc. is a clinical-stage biopharmaceutical company that focuses on developing novel therapeutics for cancer treatment. The company's main activities involve acquiring and developing antibody therapies, particularly targeting cancer-specific pathways and cell surface molecules, while also activating the immune system against cancer cells. Leap Therapeutics is engaged in multiple ongoing clinical trials for its lead product candidates. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.
Key slides for Leap Therapeutics Inc
J.P. Morgan 42nd Annual Healthcare Conference 2024
Leap Therapeutics Inc
Study Update
Leap Therapeutics Inc
Latest articles
)
House of Pinault: The History and Business of Kering and Gucci
Kering is a luxury group under the Pinault family's leadership, managing iconic brands like Gucci, Saint Laurent, and Bottega Veneta.
19 Dec 2024
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
Ticker symbol
LPTX
Country
🇺🇸 United States